Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Sensus Healthcare, Inc. before investing.

In this article, we go over a few key elements for understanding Sensus Healthcare, Inc.’s stock price such as:

• Sensus Healthcare, Inc.’s current stock price and volume
• Why Sensus Healthcare, Inc.’s stock price changed recently
• Upgrades and downgrades for SRTS from analysts
• SRTS’s stock price momentum as measured by its relative strength

About Sensus Healthcare, Inc. (SRTS)

Before we jump into Sensus Healthcare, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

Want to learn more about Sensus Healthcare, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Sensus Healthcare, Inc..

What Caused Sensus Healthcare, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 29, 2026, there were 2 analysts who downgraded Sensus Healthcare, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Sensus Healthcare, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Sensus Healthcare, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Sensus Healthcare, Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Sensus Healthcare, Inc. (SRTS) by visiting AAII Stock Evaluator.

Relative Price Strength of Sensus Healthcare, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 29, 2026, Sensus Healthcare, Inc. has a weighted four-quarter relative price strength of -17.10%, which translates to a Momentum Score of 13 and is considered to be Very Weak.

Want to learn more about how Sensus Healthcare, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Sensus Healthcare, Inc. Stock Price: Bottom Line

As of June 1, 2026, Sensus Healthcare, Inc.’s stock price is $2.820, which is down 8.74% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Sensus Healthcare, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.